Does Luminar Technologies Inc. (NASDAQ:LAZR) have deteriorating prospects?

Luminar Technologies Inc. (NASDAQ:LAZR) shares traded -1.64% lower at $5.98 on Wall Street last session. In accordance with the data, 12 analysts cover Luminar Technologies Inc. (NASDAQ:LAZR). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $20.00 and a low of $4.50, […]

There’s Still Time to Buy EQT Corporation (NYSE:EQT) Stock

In yesterday’s Wall Street session, EQT Corporation (NYSE:EQT) shares traded at $42.99, up 0.58% from the previous session. 24 analysts cover EQT Corporation (NYSE:EQT), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $65.00 and a low of […]

Do you still think Emergent BioSolutions Inc. (NYSE:EBS) is worth a look?

In yesterday’s Wall Street session, Emergent BioSolutions Inc. (NYSE:EBS) shares traded at $4.54, up 11.55% from the previous session. As of this writing, 3 analysts cover Emergent BioSolutions Inc. (NYSE:EBS). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $22.00 and a […]

Reasons why Focus Financial Partners Inc.’s (NASDAQ:FOCS) fundamentals are futile

In yesterday’s Wall Street session, Focus Financial Partners Inc. (NASDAQ:FOCS) shares traded at $52.99, down -0.02% from the previous session. 4 analysts cover Focus Financial Partners Inc. (NASDAQ:FOCS), according to research data. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $54.00 […]

Despite ImmunoGen Inc. [IMGN]’s great opportunity, the stock is a bit overvalued

In yesterday’s Wall Street session, ImmunoGen Inc. (NASDAQ:IMGN) shares traded at $15.99, up 2.90% from the previous session. 11 analysts cover ImmunoGen Inc. (NASDAQ:IMGN), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $27.00 and a low of […]